New hope that drug will slow progression of Alzheimer’s

Dr Cath Mummery (UCL Queen Square Institute of Neurology) welcomes the news that aducanumab may help to slow Alzheimer’s decline if given in higher doses and over a long period, describing the results as “very promising”.

Read: Mail Online